Coloplast A/S Class B · OMXCOP:COLO_B

Coloplast A/S Class B — ESG Presentation (March 2021)

16 slides from Coloplast A/S Class B's sustainability presentation, March 2021

  1. Slide 1: Strive25: Sustainable growth leadership

    Strive 25: Sustainable growth Stina leadership Coloplast's Sustainability Strategy Making life easier

  2. Slide 2: Agenda

    Agenda • Introduction • Our plastic position • Our new Sustainability strategy • Key 2025 priority: Products and packaging • Key 2025 priority: Reducing emissions • New commitments: Business Ambition for 1.5C and TCFD reporting • Ongoing commitment to responsible operations • Ongoing commitment to r

  3. Slide 3: Our new strategy Strive25 will drive continued long-term value creation

    Our new strategy Strive25 will drive continued long-term value creation through revenue and earnings growth Chronic Care Interventional Wound & Urology Skin Care 7-9% more than30% organic growth p.a. EBIT margin1 Talent, Innovation Leadership & Culture Unparalleled Sustainability efficiency 1) Const

  4. Slide 4: Our plastic position

    Our plastic position As a manufacturer of medical products made of plastic, Coloplast has a responsibility. We embrace that responsibility and have clear priorities: • Product safety and clinical performance cannot be compromised • Single use products are the easiest and safest option for our users

  5. Slide 5: Supporting sustainable development with emphasis on environmental performance

    Supporting sustainable development with a strong emphasis on improving our environmental performance Our mission Making life easier for people with intimate healthcare needs Stina Our 2025 priority Our 2025 priority Improving Reducing products and emissions packaging 80% packaging made from renewabl

  6. Slide 6: Our 2025 priority: Improving products and packaging

    Our 2025 priority: Improving products and packaging Improving products and packaging by addressing material use Improving products and packaging H1 2020/21 progress on key sustainability ambitions1) Why is this a key priority: 2025 H1 FY Ambition 20/21 19/20 As a manufacturer of medical products 80%

  7. Slide 7: Our 2025 priority: Reducing emissions

    Our 2025 priority: Reducing emissions We are committed to reducing emissions while being a growth company Reducing emissions H1 2020/21 progress on key sustainability ambitions1) 2025 H1 FY Why is this a key priority: Ambition 20/21 19/20 6% 6% As a growing company, we are challenged Scope 1+2 by a

  8. Slide 8: Coloplast is committed to ambitious science-based climate action

    Coloplast is committed to ambitious science-based climate action for a 1.5°C future

  9. Slide 9: Climate risk is financial risk and we support TCFD recommendations

    Climate risk is financial risk and thus we support the TCFD recommendations We support the TCFD recommendations and have decided to take a step-by-step approach to report according to the TCFD framework and will step-wise increase our disclosure in the coming years. We will report results from our c

  10. Slide 10: Our ongoing commitment: Responsible operations

    Our ongoing commitment: Responsible operations Strong commitment to responsible operations which is our core values Responsible operations H1 2020/21 progress on key sustainability ambitions1) 2025 H1 FY Why is this a key priority: Ambition 20/21 19/20 100% Our people and culture are at the center o

  11. Slide 11: Our ongoing commitment: Raising standards of care

    Our ongoing commitment: Raising standards of care We have initiated an ambitious Clinical Performance Program to tackle the biggest issues users face Users are challenged by skin irritation and urinary tract We have made progress on key technologies and infections run clinical trials Intermittent 91

  12. Slide 12: Our ongoing commitment: Raising standards of care

    Our ongoing commitment: Raising standards of care Our global Coloplast Care and DtC presence enable us to support users across countries and business areas Over 1.8M consumers in our database Over 3M conversations with users across the globe Over 30 countries with a consumer setup Coloplast Care & D

  13. Slide 13: Our ongoing commitment: Raising standards of care

    Our ongoing commitment: Raising standards of care Our Professional platform builds a strong connection with HCPs, providing valuable insights to Coloplast Care Coloplast Professional is an education and …and input from local clinicians While our training yields best collaboration platform… advance C

  14. Slide 14: Our ongoing commitment: Raising standards of care

    Our ongoing commitment: Raising standards of care Partnerships and our Access to Healthcare program have enabled increased standards of care across the globe IC reimbursement has been introduced in Japan, South Korea Access to Healthcare program and Australia over the past 5 years Our partnership pr

  15. Slide 15: Our Sustainability Governance

    Our Sustainability Governance We have strengthened our governance of Sustainability Remuneration and Nomination Committee Board of Directors Consists of three members appointed among the Consists of six shareholder-elected and three employee- Board of Directors. elected members. Audit Committee Cons

  16. Slide 16: Our mission, values and vision

    Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast Group - Ostomy Care /

Coloplast — ESG Presentation (March 2021) on 6ix